Fulton Bank N.A. Cuts Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Fulton Bank N.A. decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.9% during the 1st quarter, Holdings Channel.com reports. The firm owned 4,411 shares of the medical research company’s stock after selling 132 shares during the period. Fulton Bank N.A.’s holdings in Thermo Fisher Scientific were worth $2,014,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of TMO. Norges Bank purchased a new position in Thermo Fisher Scientific in the fourth quarter valued at approximately $2,336,640,000. FMR LLC raised its holdings in Thermo Fisher Scientific by 5.6% during the 4th quarter. FMR LLC now owns 13,022,987 shares of the medical research company’s stock valued at $6,065,847,000 after acquiring an additional 686,768 shares during the period. BlackRock Inc. raised its holdings in Thermo Fisher Scientific by 2.2% during the 4th quarter. BlackRock Inc. now owns 29,504,221 shares of the medical research company’s stock valued at $13,742,475,000 after acquiring an additional 624,512 shares during the period. Bank Julius Baer & Co. Ltd Zurich raised its holdings in Thermo Fisher Scientific by 473.7% during the 4th quarter. Bank Julius Baer & Co. Ltd Zurich now owns 641,921 shares of the medical research company’s stock valued at $298,994,000 after acquiring an additional 530,026 shares during the period. Finally, Veritas Investment Partners UK Ltd. bought a new stake in Thermo Fisher Scientific during the 4th quarter valued at $156,804,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

A number of equities research analysts have issued reports on the stock. Citigroup boosted their target price on shares of Thermo Fisher Scientific from $500.00 to $530.00 and gave the company a “buy” rating in a report on Tuesday, February 2nd. Stifel Nicolaus upped their price target on shares of Thermo Fisher Scientific from $530.00 to $600.00 and gave the stock a “buy” rating in a report on Tuesday, February 2nd. UBS Group reduced their target price on Thermo Fisher Scientific from $588.00 to $560.00 and set a “buy” rating on the stock in a research note on Monday, March 29th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell cut Thermo Fisher Scientific from a “buy” rating to a “neutral” rating and reduced their target price for the company from $550.00 to $500.00 in a research note on Wednesday, December 16th. Finally, BTIG Research increased their target price on Thermo Fisher Scientific from $540.00 to $590.00 and gave the company a “buy” rating in a research note on Wednesday, February 3rd. Four equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $524.45.

Shares of TMO opened at $473.61 on Thursday. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.93 and a quick ratio of 2.31. Thermo Fisher Scientific Inc. has a one year low of $290.52 and a one year high of $532.57. The company has a 50-day simple moving average of $456.46 and a two-hundred day simple moving average of $470.87. The firm has a market capitalization of $186.50 billion, a PE ratio of 38.23, a price-to-earnings-growth ratio of 1.40 and a beta of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Sunday, January 31st. The medical research company reported $7.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $6.56 by $0.53. Thermo Fisher Scientific had a net margin of 17.12% and a return on equity of 21.35%. The business had revenue of $10.55 billion during the quarter, compared to analyst estimates of $9.53 billion. During the same period last year, the business posted $3.55 earnings per share. Thermo Fisher Scientific’s quarterly revenue was up 54.5% compared to the same quarter last year. Analysts expect that Thermo Fisher Scientific Inc. will post 19.03 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 16th. Shareholders of record on Tuesday, March 16th will be issued a $0.26 dividend. The ex-dividend date is Monday, March 15th. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.22. This represents a $1.04 annualized dividend and a yield of 0.22%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 8.42%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Featured Story: What are momentum indicators and what do they show?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.